Michael F. Demane - Jun 7, 2023 Form 4 Insider Report for NEVRO CORP (NVRO)

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael F. DeMane
Stock symbol
NVRO
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:36 PM
Previous filing
May 30, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Gift $0 -80K -74.23% $0.00 27.8K Jun 7, 2023 Direct F1
holding NVRO Common Stock 164K Jun 7, 2023 See footnote F2
holding NVRO Common Stock 123K Jun 7, 2023 See footnote F3, F6
holding NVRO Common Stock 131K Jun 7, 2023 See footnote F4, F6
holding NVRO Common Stock 18.3K Jun 7, 2023 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 6,754 restricted stock units.
F2 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
F4 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
F5 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
F6 Reflects the transfer of 40,000 directly held shares to each of the SLAT Trust and the 2011 Trust on June 7, 2023.